Search

Memorial Sloan Kettering Cancer Center (MSK) and Curadev Pharma, Inc., a biotechnology company developing novel immuno-oncology therapeutics, are expanding their collaboration through the MSK Therapeutics Accelerator program to advance the development of CRD3874-SI, Curadev’s first-in-class allosteric stimulator of interferon genes (STING) agonist for solid tumors.

… Friday, June 20, 2025 Memorial Sloan Kettering Cancer Center (MSK) and Curadev Pharma, Inc., a biotechnology company developing novel immuno-oncology therapeutics, are expanding their collaboration through the MSK Therapeutics Accelerator program to advance the development of CRD3874-SI, Curadev’s first-in-class

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.

… Wednesday, December 20, 2023 When Christopher Klebanoff, MD , came to Memorial Sloan Kettering Cancer Center (MSK) from the National Cancer Institute in 2016, he was focused on a singular goal: bringing the promise of cellular immunotherapies to the more than 80% of cancers that as yet lack an effective

Discover the significance of the Josie Robertson Surgery Center’s signature art piece.

… Thursday, January 26, 2017 VIDEO | 03:27 Wordfall Take a closer look at Wordfall, which was created in memory of a gifted young poet, Brendan Ogg. Video Details Summary Visitors to Memorial Sloan Kettering’s Josie Robertson Surgery Center — which opened one year ago — will first notice the cascading

Learn how MSK nurse practitioner Mindy Jaffe guides children and young adults with cancer and their families through their reproductive options.

… Monday, January 15, 2018 Learning that cancer treatments can affect a child’s fertility can make already difficult conversations even harder. Mindy Jaffe at MSK makes those discussions go a bit smoother. As a nurse practitioner in MSK’s Cancer and Fertility Program , Ms. Jaffe counsels young patients

Get to know Ashley Chui, a chemical biology graduate student in the Sloan Kettering Institute.

… Monday, March 23, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Ashley Chui is a graduate student in the Bachovchin lab  in the Sloan Kettering Institute. When and how did you

Joan Argetsinger Steitz, PhD, Sterling Professor of Molecular Biophysics and Biochemistry at Yale School of Medicine, will also be honored with the 2021 Honorary Degree and the MSK Medal for Outstanding Contributions to Biomedical Research.

… Wednesday, May 19, 2021 VIDEO | MSK Tassel Turn 2021 MSK Tassel Turn 2021 Video Details During a virtual commencement ceremony on Wednesday, May 19, 2021, at 3:00 p.m. et, Memorial Sloan Kettering Cancer Center (MSK) will recognize seven Gerstner Sloan Kettering (GSK) 2021 graduates and honor Joan Argetsinger

A low-dose radiation approach could help more patients avoid side effects of treatment for head and neck cancer.

… Thursday, January 20, 2022 Robert Rosenfeld thought the lump he felt in his neck in late 2018 was just a symptom of a cold that wouldn’t go away. He visited an ear, nose, and throat specialist who saw nothing upon first examination, but Robert knew something was wrong and asked for a CT scan. The specialist

Several MSK physicians and researchers presenting during the plenary sessions.

… Thursday, April 8, 2021 Thousands of oncology experts from around the world will tune in April 10-15 for the American Association for Cancer Research’s (AACR) Annual Meeting: Week 1 . The meeting is the first of two virtual meetings, with clinical trial plenary sessions, clinical trial poster sessions

A surprising discovery linking the hormone insulin to skin pigmentation offers fresh insights into how animal bodies take shape.

… Thursday, May 24, 2018 Summary Scientists at the Sloan Kettering Institute have made a surprising find about how the hormone insulin contributes to skin pigmentation in fish. The discovery may have implications for human cancer. If you’re a zebra, you want your stripes in order. Come to the savannah

Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.

… Thursday, September 4, 2014 Summary Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response. An international team of researchers led by Memorial